Study suggests strong ‘nocebo’ effect in patients with IBS when it comes to glutenResearchers found the number of people who experienced worse IBS symptoms was similar across all three patient groups, including those given a gluten-free placebo to eat. POP QUIZ: Management of hemorrhoidsA recent JAMA article reviewed the management of hemorrhoids. How should hemorrhoids be optimally managed? New article reviews the current evidence on epidemiology, pathophysiology, diagnosis and treatment of hemorrhoidal disease. Long-term prescription opioids linked to increased risk of esophageal dysfunction Canadian product monographs for prescription opioids are being updated to include the risk of esophageal dysfunction with long-term opioid use. Does owning a dog pay dividends when it comes to eczema? Canine exposure may protect against eczema by tamping gene activity. QUIZ: How much do you know about helicobacter pylori? Have you kept up with the latest on testing and treatment for H. pylori infection? Find out here! Do we really need the robot? Laparoscopic vs. robotic-assisted cholecystectomy The minimally invasive laparoscopic approach already has a great safety rep. Updated Canadian guidelines for management of chronic hepatitis B 2025 CASL/AMMI Canada guidelines present recommendations for universal adult HBV screening, vaccination, laboratory assessment and treatment. OTC survey 2025: Top recommended brands for gastric issues Between October 2024 and January 2025, more than 1,800 pharmacists and 800 physicians were asked about which brands they personally recommend. NEW PRODUCT: Iqirvo Get the info you need on this new product, part of our drug news roundup for July. 1 2 3 4 5 Next Last
